UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
x |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 28, 2015
Commission file number 000-49602
SYNAPTICS INCORPORATED
(Exact name of registrant as specified in its charter)
Delaware |
|
77-0118518 |
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
1251 McKay Drive
San Jose, California 95131
(Address of principal executive offices) (Zip code)
(408) 904-1100
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer |
|
x |
|
Accelerated filer |
|
¨ |
|
|
|
|
|||
Non-accelerated filer |
|
¨ (Do not check if a smaller reporting company) |
|
Smaller reporting company |
|
¨ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x
Number of shares of Common Stock outstanding at April 24, 2015: 36,831,918
SYNAPTICS INCORPORATED
QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTER ENDED MARCH 28, 2015
TABLE OF CONTENTS
|
|
|
|
|
|
Page |
|
|
|||||
|
|
|
|
|||
|
|
Item 1. |
|
|
3 |
|
|
|
|
|
|||
|
|
|
|
Condensed Consolidated Balance Sheets—March 31, 2015 and June 30, 2014 |
|
3 |
|
|
|
|
|||
|
|
|
|
|
4 |
|
|
|
|
|
|||
|
|
|
|
|
5 |
|
|
|
|
|
|||
|
|
|
|
Condensed Consolidated Statements of Cash Flows—Nine Months Ended March 31, 2015 and 2014 |
|
6 |
|
|
|
|
|||
|
|
|
|
|
7 |
|
|
|
|
|
|||
|
|
Item 2. |
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
|
20 |
|
|
|
|
|||
|
|
Item 3. |
|
|
28 |
|
|
|
|
|
|||
|
|
Item 4. |
|
|
29 |
|
|
|
|||||
|
|
|||||
|
|
|
|
|||
|
|
Item 2. |
|
|
30 |
|
|
|
|
|
|||
|
|
Item 6. |
|
|
31 |
|
|
|
|||||
|
32 |
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
SYNAPTICS INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)
(unaudited)
|
|
March 31, |
|
|
June 30, |
|
||
|
|
2015 |
|
|
2014 |
|
||
ASSETS |
|
|
|
|
|
|
|
|
Current Assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
380,579 |
|
|
$ |
447,205 |
|
Accounts receivable, net of allowances of $1,800 and $883 at March 31, 2015 and June 30, 2014, respectively |
|
|
319,567 |
|
|
|
195,057 |
|
Inventories |
|
|
152,261 |
|
|
|
82,311 |
|
Prepaid expenses and other current assets |
|
|
27,634 |
|
|
|
17,858 |
|
Total current assets |
|
|
880,041 |
|
|
|
742,431 |
|
Property and equipment at cost, net of accumulated depreciation of $66,662 and $49,482 at March 31, 2015 and June 30, 2014, respectively |
|
|
117,692 |
|
|
|
80,849 |
|
Goodwill |
|
|
215,244 |
|
|
|
61,030 |
|
Acquired intangibles, net |
|
|
254,357 |
|
|
|
82,111 |
|
Non-current other assets |
|
|
43,883 |
|
|
|
53,912 |
|
|
|
$ |
1,511,217 |
|
|
$ |
1,020,333 |
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
|
|
|
|
Current Liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
182,021 |
|
|
$ |
97,109 |
|
Accrued compensation |
|
|
32,217 |
|
|
|
30,682 |
|
Income taxes payable |
|
|
34,136 |
|
|
|
12,538 |
|
Acquisition-related liabilities |
|
|
42,976 |
|
|
|
57,388 |
|
Other accrued liabilities |
|
|
96,908 |
|
|
|
56,691 |
|
Current portion of long-term debt |
|
|
9,375 |
|
|
|
— |
|
Total current liabilities |
|
|
397,633 |
|
|
|
254,408 |
|
Long-term debt, net of issuance costs |
|
|
234,581 |
|
|
|
— |
|
Acquisition-related liabilities |
|
|
72,734 |
|
|
|
52,734 |
|
Deferred tax liabilities |
|
|
43,341 |
|
|
|
— |
|
Other long-term liabilities |
|
|
14,634 |
|
|
|
12,034 |
|
Total liabilities |
|
|
762,923 |
|
|
|
319,176 |
|
Stockholders' Equity: |
|
|
|
|
|
|
|
|
Common stock: |
|
|
|
|
|
|
|
|
$0.001 par value; 120,000,000 shares authorized, 57,392,290 and 55,911,513 shares issued, and 36,798,673 and 36,863,802 shares outstanding, at March 31, 2015 and June 30, 2014, respectively |
|
|
57 |
|
|
|
56 |
|
Additional paid-in capital |
|
|
819,462 |
|
|
|
740,282 |
|
Treasury stock: 20,593,617 and 19,047,711 common treasury shares at March 31, 2015 and June 30, 2014, respectively, at cost |
|
|
(641,022 |
) |
|
|
(530,422 |
) |
Accumulated other comprehensive income |
|
|
8,075 |
|
|
|
8,560 |
|
Retained earnings |
|
|
561,722 |
|
|
|
482,681 |
|
Total stockholders' equity |
|
|
748,294 |
|
|
|
701,157 |
|
|
|
$ |
1,511,217 |
|
|
$ |
1,020,333 |
|
See accompanying notes to condensed consolidated financial statements (unaudited).
3
SYNAPTICS INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)
(in thousands, except per share data)
(unaudited)
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
March 31, |
|
|
March 31, |
|
||||||||||
|
|
2015 |
|
|
2014 |
|
|
2015 |
|
|
2014 |
|
||||
Net revenue |
|
$ |
477,598 |
|
|
$ |
204,271 |
|
|
$ |
1,224,044 |
|
|
$ |
632,641 |
|
Cost of revenue |
|
|
313,253 |
|
|
|
111,841 |
|
|
|
812,679 |
|
|
|
336,387 |
|
Gross margin |
|
|
164,345 |
|
|
|
92,430 |
|
|
|
411,365 |
|
|
|
296,254 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
|
78,719 |
|
|
|
49,412 |
|
|
|
213,467 |
|
|
|
135,785 |
|
Selling, general, and administrative |
|
|
35,803 |
|
|
|
25,856 |
|
|
|
88,532 |
|
|
|
69,825 |
|
Acquired intangibles amortization |
|
|
4,658 |
|
|
|
262 |
|
|
|
9,577 |
|
|
|
785 |
|
Change in contingent consideration |
|
|
(6,688 |
) |
|
|
53,043 |
|
|
|
(18,311 |
) |
|
|
56,731 |
|
Total operating expenses |
|
|
112,492 |
|
|
|
128,573 |
|
|
|
293,265 |
|
|
|
263,126 |
|
Operating income/(loss) |
|
|
51,853 |
|
|
|
(36,143 |
) |
|
|
118,100 |
|
|
|
33,128 |
|
Interest and other income, net |
|
|
349 |
|
|
|
516 |
|
|
|
1,470 |
|
|
|
1,422 |
|
Interest expense |
|
|
(1,317 |
) |
|
|
— |
|
|
|
(2,529 |
) |
|
|
(9 |
) |
Income/(loss) before provision for income taxes |
|
|
50,885 |
|
|
|
(35,627 |
) |
|
|
117,041 |
|
|
|
34,541 |
|
Provision for income taxes |
|
|
19,407 |
|
|
|
4,429 |
|
|
|
38,000 |
|
|
|
22,324 |
|
Net income/(loss) |
|
$ |
31,478 |
|
|
$ |
(40,056 |
) |
|
$ |
79,041 |
|
|
$ |
12,217 |
|
Net income/(loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.86 |
|
|
$ |
(1.12 |
) |
|
$ |
2.15 |
|
|
$ |
0.36 |
|
Diluted |
|
$ |
0.82 |
|
|
$ |
(1.12 |
) |
|
$ |
2.04 |
|
|
$ |
0.33 |
|
Shares used in computing net income/(loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
36,726 |
|
|
|
35,685 |
|
|
|
36,839 |
|
|
|
34,212 |
|
Diluted |
|
|
38,535 |
|
|
|
35,685 |
|
|
|
38,797 |
|
|
|
36,532 |
|
See accompanying notes to condensed consolidated financial statements (unaudited).
4
SYNAPTICS INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(in thousands)
(unaudited)
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
March 31, |
|
|
March 31, |
|
||||||||||
|
|
2015 |
|
|
2014 |
|
|
2015 |
|
|
2014 |
|
||||
Net income/(loss) |
|
$ |
31,478 |
|
|
$ |
(40,056 |
) |
|
$ |
79,041 |
|
|
$ |
12,217 |
|
Other comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in unrealized net gain on investments |
|
|
347 |
|
|
|
306 |
|
|
|
561 |
|
|
|
1,597 |
|
Reclassification from accumulated other comprehensive income to interest income for accretion of non-current investments |
|
|
(377 |
) |
|
|
(278 |
) |
|
|
(1,046 |
) |
|
|
(751 |
) |
Net current-period other comprehensive income/(loss) |
|
|
(30 |
) |
|
|
28 |
|
|
|
(485 |
) |
|
|
846 |
|
Comprehensive income/(loss) |
|
$ |
31,448 |
|
|
$ |
(40,028 |
) |
|
$ |
78,556 |
|
|
$ |
13,063 |
|
See accompanying notes to condensed consolidated financial statements (unaudited).
5
SYNAPTICS INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
|
|
Nine Months Ended |
|
|||||
|
|
March 31, |
|
|||||
|
|
2015 |
|
|
2014 |
|
||
Cash flows from operating activities |
|
|
|
|
|
|
|
|
Net income |
|
$ |
79,041 |
|
|
$ |
12,217 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
|
Share-based compensation costs |
|
|
31,837 |
|
|
|
23,439 |
|
Depreciation and amortization |
|
|
17,251 |
|
|
|
10,353 |
|
Acquired intangibles amortization |
|
|
68,654 |
|
|
|
4,759 |
|
Accretion and remeasurement of contingent consideration liability |
|
|
(18,311 |
) |
|
|
56,731 |
|
Deferred taxes |
|
|
(13,637 |
) |
|
|
8,483 |
|
Impairment recovery on investments |
|
|
(179 |
) |
|
|
— |
|
Non-cash interest income |
|
|
(1,046 |
) |
|
|
(751 |
) |
Amortization of debt issuance costs |
|
|
504 |
|
|
|
— |
|
Foreign currency remeasurement gain |
|
|
(7,363 |
) |
|
|
— |
|
Changes in operating assets and liabilities, net of acquisitions: |
|
|
|
|
|
|
|
|
Accounts receivable, net |
|
|
5,780 |
|
|
|
2,607 |
|
Inventories |
|
|
(63,636 |
) |
|
|
(18,086 |
) |
Prepaid expenses and other current assets |
|
|
30,929 |
|
|
|
(673 |
) |
Other assets |
|
|
8,622 |
|
|
|
(8,727 |
) |
Accounts payable |
|
|
26,441 |
|
|
|
(5,823 |
) |
Accrued compensation |
|
|
(1,750 |
) |
|
|
(2,339 |
) |
Income taxes payable |
|
|
(7,123 |
) |
|
|
(4,259 |
) |
Other accrued liabilities |
|
|
16,518 |
|
|
|
13,172 |
|
Net cash provided by operating activities |
|
|
172,532 |
|
|
|
91,103 |
|
Cash flows from investing activities |
|
|
|
|
|
|
|
|
Proceeds from sales of non-current investments |
|
|
4,900 |
|
|
|
— |
|
Acquisition of business, net of cash acquired |
|
|
(294,282 |
) |
|
|
(19,620 |
) |
Purchases of property and equipment |
|
|
(40,864 |
) |
|
|
(32,321 |
) |
Net cash used in investing activities |
|
|
(330,246 |
) |
|
|
(51,941 |
) |
Cash flows from financing activities |
|
|
|
|
|
|
|
|
Payment of acquisition-related liabilities |
|
|
(63,761 |
) |
|
|
— |
|
Purchases of treasury stock |
|
|
(110,600 |
) |
|
|
(70,262 |
) |
Proceeds from issuance of shares |
|
|
24,480 |
|
|
|
62,997 |
|
Proceeds from issuance of long-term debt |
|
|
245,367 |
|
|
|
— |
|
Payment of debt issuance costs |
|
|
(400 |
) |
|
|
— |
|
Excess tax benefit from share-based compensation |
|
|
13,223 |
|
|
|
12,946 |
|
Payroll taxes for deferred stock and market stock units |
|
|
(12,062 |
) |
|
|
(6,406 |
) |
Payment of debt |
|
|
(1,875 |
) |
|
|
(2,259 |
) |
Net cash provided by/(used in) financing activities |
|
|
94,372 |
|
|
|
(2,984 |
) |
Effect of exchange rate changes on cash and cash equivalents |
|
|
(3,284 |
) |
|
|
— |
|
Net increase/(decrease) in cash and cash equivalents |
|
|
(66,626 |
) |
|
|
36,178 |
|
Cash and cash equivalents at beginning of period |
|
|
447,205 |
|
|
|
355,303 |
|
Cash and cash equivalents at end of period |
|
$ |
380,579 |
|
|
$ |
391,481 |
|
Supplemental disclosures of cash flow information |
|
|
|
|
|
|
|
|
Cash paid for taxes |
|
$ |
41,945 |
|
|
$ |
15,311 |
|
Non-cash investing and financing activities: |
|
|
|
|
|
|
|
|
Property and equipment received but unpaid |
|
$ |
4,833 |
|
|
$ |
1,890 |
|
Common stock issued pursuant to acquisition |
|
$ |
— |
|
|
$ |
70,280 |
|
Common stock issued in settlement of contingent consideration liability |
|
$ |
21,487 |
|
|
$ |
37,499 |
|
See accompanying notes to condensed consolidated financial statements (unaudited).
6
SYNAPTICS INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
1. Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission, or the SEC, and U.S. generally accepted accounting principles, or U.S. GAAP. However, certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to SEC rules and regulations. In our opinion, the financial statements include all adjustments, which are of a normal and recurring nature and necessary for the fair presentation of the results of the interim periods presented. The results of operations for the interim periods are not necessarily indicative of the operating results for the full fiscal year or any future period. These financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended June 28, 2014.
The consolidated financial statements include our financial statements and those of our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated upon consolidation.
Our fiscal year is the 52- or 53-week period ending on the last Saturday in June. Our fiscal 2015 and 2014 years are 52-week periods ending on June 27, 2015 and June 28, 2014, respectively. The quarterly fiscal periods presented in this report were 13-week periods for the three months ended March 28, 2015 and March 29, 2014, respectively. For ease of presentation, the accompanying consolidated financial statements have been shown as ending on calendar quarter end dates as of and for all periods presented, unless otherwise indicated.
Use of Estimates
The preparation of consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to revenue recognition, allowance for doubtful accounts, cost of revenue, inventories, loss on purchase commitments, product warranty, share-based compensation costs, provision for income taxes, deferred income tax asset valuation allowances, uncertain tax positions, goodwill, intangible assets, investments, contingent consideration liabilities, and loss contingencies. We base our estimates on historical experience, applicable laws and regulations, and various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
Foreign Currency Transactions and Foreign Exchange Contracts
We use the U.S. dollar as our functional currency for financial reporting and therefore foreign currency transaction and remeasurement gains and losses are included in results of operations and are primarily the result of revaluing assets and liabilities denominated in a currency other than the functional currency. These foreign currency transactions and remeasurement gains and losses, which primarily related to our recent acquisition of Renesas SP Drivers, Inc., resulted in a net loss of $0.8 million in the three months ended March 28, 2015, and a net gain of $14.1 million in the nine months ended March 28, 2015, and are included in selling, general, and administrative expenses in the condensed consolidated statements of income. Amounts resulting from such foreign currency transactions were not material in the similar prior year periods.
We also enter into foreign currency contracts to manage exposure related to certain foreign currency obligations. The foreign currency contracts are not designated as hedging instruments and, accordingly, are not subject to hedge accounting. In March 2015, we entered into foreign currency forward contracts to purchase Japanese yen, using U.S. dollars. As of March 31, 2015, we had outstanding foreign currency forward contracts totaling ¥6.0 billion for a total of $50.0 million, at an average exchange rate of 120.47. The value date of the foreign currency forward contracts is March 11, 2016. The net fair value of the outstanding foreign currency forward contracts is disclosed in Note 4 Fair Value, and is recorded as an asset under prepaid expenses and other current assets in the condensed consolidated balance sheets. In the three months ended March 31, 2015, we recognized net unrealized gains of $0.7 million on the foreign currency forward contracts, which are recorded in selling, general, and administrative expenses in the condensed consolidated statements of income.
2. Revenue Recognition
We recognize revenue from product sales when there is persuasive evidence that an arrangement exists, delivery has occurred and title has transferred, the price is fixed or determinable, and collection is reasonably assured. We accrue for estimated sales returns,
7
incentives, and other allowances at the time we recognize revenue. Our products contain embedded firmware and software, which together with, or consisting of, our ASIC chip, deliver the essential functionality of our products and, as such, software revenue recognition guidance is not applicable.
3. Net Income/(Loss) Per Share
The computation of basic and diluted net income/(loss) per share was as follows (in thousands, except per share data):
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
March 31, |
|
|
March 31, |
|
||||||||||
|
|
2015 |
|
|
2014 |
|
|
2015 |
|
|
2014 |
|
||||
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income/(loss) |
|
$ |
31,478 |
|
|
$ |
(40,056 |
) |
|
$ |
79,041 |
|
|
$ |
12,217 |
|
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares, basic |
|
|
36,726 |
|
|
|
35,685 |
|
|
|
36,839 |
|
|
|
34,212 |
|
Effect of dilutive share-based awards |
|
|
1,809 |
|
|
|
— |
|
|
|
1,958 |
|
|
|
2,320 |
|
Shares, diluted |
|
|
38,535 |
|
|
|
35,685 |
|
|
|
38,797 |
|
|
|
36,532 |
|
Net income/(loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.86 |
|
|
$ |
(1.12 |
) |
|
$ |
2.15 |
|
|
$ |
0.36 |
|
Diluted |
|
$ |
0.82 |
|
|
$ |
(1.12 |
) |
|
$ |
2.04 |
|
|
$ |
0.33 |
|
Our basic net income/(loss) per share amounts for each period presented have been computed using the weighted average number of shares of common stock outstanding. Our diluted net income per share amounts for each period presented include the weighted average effect of potentially dilutive shares. We use the “treasury stock” method to determine the dilutive effect of our stock options, deferred stock units, or DSUs, and market stock units, or MSUs.
Dilutive net income/(loss) per share amounts do not include the potential weighted average effect of 380,506 and 2,481,307 shares of common stock related to certain share-based awards that were outstanding during the three months ended March 31, 2015 and 2014, respectively, and 370,296 and 356,878 shares of common stock related to certain share-based awards that were outstanding during the nine months ended March 31, 2015 and 2014, respectively. These share-based awards were not included in the computation of diluted net income/(loss) per share because their effect would have been antidilutive.
4. Fair Value
Financial assets and liabilities, measured at fair value on a recurring basis by level within the fair value hierarchy, consisted of the following (in thousands):
|
|
March 31, |
|
|
June 30, |
|
||||||||||||||
|
|
2015 |
|
|
2014 |
|
||||||||||||||
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Level 1 |
|
|
Level 3 |
|
|||||
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
$ |
347,778 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
439,675 |
|
|
$ |
— |
|
Auction rate securities |
|
|
— |
|
|
|
— |
|
|
|
15,625 |
|
|
|
— |
|
|
|
19,785 |
|
Total available-for-sale securities |
|
$ |
347,778 |
|
|
$ |
— |
|
|
$ |
15,625 |
|
|
$ |
439,675 |
|
|
$ |
19,785 |
|
Foreign currency contract assets |
|
$ |
— |
|
|
$ |
693 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contingent consideration liabilities recorded for business combinations |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
55,121 |
|
|
$ |
— |
|
|
$ |
110,122 |
|
In our condensed consolidated balance sheets as of March 31, 2015 and June 30, 2014, money market balances were included in cash and cash equivalents and auction rate securities, or ARS investments, were included in non-current other assets; $600,000 of the ARS investments were included in prepaid expenses and other current assets as of March 31, 2015.
We measure our foreign currency contracts at fair value on a recurring basis. We utilized Level 2 inputs to value the foreign currency forward contracts. Specifically, we utilized quoted prices for similar assets or liabilities in markets that are not active. Key
8
inputs for the foreign currency forward contracts are currency and interest forward rates. The foreign currency contracts were included in prepaid expenses and other current assets as of March 31, 2015.
The contingent consideration liability recorded for business combinations was included in acquisition-related liabilities as of March 31, 2015 and June 30, 2014, respectively.
Changes in fair value of our Level 3 financial assets as of March 31, 2015 were as follows (in thousands):
Balance as of June 30, 2014 |
|
$ |
19,785 |
|
Net gain |
|
|
740 |
|
Redemptions |
|
|
(4,900 |
) |
Balance as of March 31, 2015 |
|
$ |
15,625 |
|
Changes in fair value of our Level 3 contingent consideration liabilities as of March 31, 2015 were as follows (in thousands):
Balance as of June 30, 2014 |
|
$ |
110,122 |
|
Cash settlement of contingent consideration liability |
|
|
(15,203 |
) |
Issuance of common stock in settlement of liability |
|
|
(21,487 |
) |
Accretion and remeasurement |
|
|
(18,311 |
) |
Balance as of March 31, 2015 |
|
$ |
55,121 |
|
In connection with our acquisition of Validity Sensors, Inc., or Validity, we entered into a contingent consideration arrangement. As of March 31, 2015, we may be required to make additional cash payments of up to $122.5 million as consideration to the former Validity stockholders and option holders based on unit sales of products utilizing Validity technology through March 2016.
In connection with our acquisition of Pacinian Corporation, or Pacinian, we entered into a contingent consideration arrangement. As of March 31, 2015, we may be required to make additional cash payments of up to $10.0 million as consideration to the former Pacinian stockholders based on unit sales of products utilizing ThinTouch technology through June 2016.
Changes in the fair value of our contingent consideration liabilities subsequent to the Validity and Pacinian acquisitions are included in operating expenses as change in contingent consideration in the condensed consolidated statements of income (loss). Cash payments of contingent consideration are classified in the condensed consolidated statements of cash flows as a financing activity up to the amount of the contingent consideration recorded at the time of the acquisition, and as an operating activity for cash payments that exceed the liability recorded at the time of acquisition.
There were no transfers in or out of our Level 1, 2, or 3 assets or liabilities during the three and nine months ended March 31, 2015 and 2014.
The fair values of our accounts receivable and accounts payable approximate their carrying values because of the short-term nature of those instruments. Intangible assets, property and equipment, and goodwill are measured at fair value on a non-recurring basis if impairment is indicated. The interest rate on our bank debt is variable, which is subject to change from time to time to reflect a market interest rate; accordingly, the carrying value of our bank debt approximates fair value.
5. Non-Current Other Assets
Our non-current investments, which are included in non-current other assets in the condensed consolidated balance sheets, consist of ARS investments, which have failed to settle in auctions and are not liquid. In the event we need to access these funds prior to their maturity, we will not be able to do so without a loss of principal, unless redeemed by the issuers or a future auction on these investments is successful. During the nine months ended March 31, 2015, $4.9 million of our ARS investments were redeemed at par value.
As there are currently no active markets for our ARS investments, we have estimated the fair value of these investments as of March 31, 2015 using a trinomial discounted cash flow analysis. The analysis considered, among others, the following factors:
· |
the collateral underlying the security investments; |
· |
the creditworthiness of the counterparty; |
· |
the timing of expected future cash flows; |
9
· |
the probability of a successful auction in a future period; |
· |
the underlying structure of each investment; |
· |
the present value of future principal and interest payments discounted at rates considered to reflect current market conditions; |
· |
a consideration of the probabilities of default, a successful future auction, or redemption at par for each period; and |
· |
estimates of the recovery rates in the event of default for each investment. |
When possible, our ARS investments were compared to other observable market data or securities with similar characteristics. Our estimate of the fair value of our ARS investments could change materially from period to period based on future market conditions.
We have ARS investments with a fair value of $12.8 million maturing from fiscal years 2016 to 2018 and $2.8 million fair value with no maturity date. Of our ARS investments, $600,000 par value are investment grade, and the remaining $18.5 million par value are below investment grade.
The various types of ARS investments we held as of March 31, 2015, including the original cost basis, other-than-temporary impairment included in retained earnings, new cost basis, unrealized gain, and fair value, consisted of the following (in thousands):
|
|
Original Cost Basis |
|
|
Other-than- temporary Impairment in Retained Earnings |
|
|
New Cost Basis |
|
|
Unrealized Gain |
|
|
Fair Value |
|
|||||
Credit linked notes |
|
$ |
13,500 |
|
|
$ |
(6,467 |
) |
(1) |
$ |
7,033 |
|
|
$ |
5,248 |
|
|
$ |
12,281 |
|
Preferred stock |
|
|
5,000 |
|
|
|
(5,000 |
) |
|
|
— |
|
|
|
2,750 |
|
|
|
2,750 |
|
Municipals |
|
|
600 |
|
|
|
(83 |
) |
|
|
517 |
|
|
|
77 |
|
|
|
594 |
|
Total ARS |
|
$ |
19,100 |
|
|
$ |
(11,550 |
) |
|
$ |
7,550 |
|
|
$ |
8,075 |
|
|
$ |
15,625 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Other-than-temporary impairment in retained earnings is partially offset by cumulative accretion of $2.3 million on non-current investments. Accretion is reclassified from accumulated other comprehensive income and recorded in the condensed consolidated statements of income as non-cash interest income. |
|
The various types of ARS investments we held as of June 30, 2014, including the original cost basis, other-than-temporary impairment included in retained earnings, new cost basis, unrealized gain/(loss), and fair value, consisted of the following (in thousands):
|
|
Original Cost Basis |
|
|
Other-than- temporary Impairment in Retained Earnings |
|
|
New Cost Basis |
|
|
Unrealized Gain/(Loss) |
|
|
Fair Value |
|
|||||
Student loans |
|
$ |
3,500 |
|
|
$ |
(179 |
) |
|
$ |
3,321 |
|
|
$ |
(149 |
) |
|
$ |
3,172 |
|
Credit linked notes |
|
|
13,500 |
|
|
|
(7,513 |
) |
(1) |
|
5,987 |
|
|
|
5,891 |
|
|
|
11,878 |
|
Preferred stock |
|
|
5,000 |
|
|
|
(5,000 |
) |
|
|
— |
|
|
|
2,750 |
|
|
|
2,750 |
|
Municipals |
|
|
2,000 |
|
|
|
(83 |
) |
|
|
1,917 |
|
|
|
68 |
|
|
|
1,985 |
|
Total ARS |
|
$ |
24,000 |
|
|
$ |
(12,775 |
) |
|
$ |
11,225 |
|
|
$ |
8,560 |
|
|
$ |
19,785 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Other-than-temporary impairment in retained earnings is partially offset by cumulative accretion of $1.3 million on non-current investments. Accretion is reclassified from accumulated other comprehensive income and recorded in the condensed consolidated statements of income as non-cash interest income. |
|
The student loan ARS investments in the above table with unrealized losses have been in a continuous unrealized loss position for more than 12 months.
10
We have accounted for all of our ARS investments with maturity dates of more than 12 months from the balance sheet date as non-current as we are not able to reasonably determine when the ARS markets will recover or be restructured. Based on our ability to access our cash and cash equivalents, our expected operating cash flows, and our other sources of cash, we do not intend to sell the ARS investments, and it is not more likely than not that we will be required to sell the investments before the recovery of the amortized cost basis.
6. Inventories
Inventories are stated at the lower of cost (first-in, first-out method) or market (estimated net realizable value) and consisted of the following (in thousands):
|
|
March 31, |
|
|
June 30, |
|
||
|
|
2015 |
|
|
2014 |
|
||
Raw materials |
|
$ |
83,772 |
|
|
$ |
58,717 |
|
Finished goods |
|
|
68,489 |
|
|
|
23,594 |
|
|
|
$ |
152,261 |
|
|
$ |
82,311 |
|
7. Acquisition
On June 11, 2014, we entered into a stock purchase agreement to acquire all of the outstanding stock of Renesas SP Drivers, Inc., or RSP, a leading provider of small- and medium-sized display driver integrated circuits for smartphones and tablets, or the RSP Acquisition. The RSP Acquisition is intended to accelerate our product roadmap for high-performance, low-cost display integration products, strengthen our relationships with key customers, and create opportunities to drive increased revenue. Effective as of October 1, 2014, or the Closing Date, we completed the RSP Acquisition of 100% of the outstanding capital stock of RSP for an initial purchase price of approximately ¥50.6 billion (or approximately $463 million), with Japanese yen converted into U.S. dollars at the Closing Date conversion rate of 109.4 Japanese yen to one U.S. dollar. The purchase price the Closing Date was paid entirely in cash, with ¥7.25 billion (or approximately $66 million) held back until the date that is 18 months after the Closing Date to address any post-closing adjustments or claims, or the Indemnification Holdback, and ¥5.25 billion (or approximately $48 million) held back in respect of a potential post-closing working capital, cash balance, indebtedness and transaction expenses adjustments, or the Working Capital Holdback. Subsequent to the Closing Date, we determined that $4.8 million of additional purchase consideration was due to the sellers pursuant to the requirements of the Working Capital Holdback and have adjusted the purchase price to $468 million. We anticipate settlement of the Indemnification Holdback to occur in the fourth quarter of fiscal 2016.
The Working Capital Holdback as adjusted for additional purchase consideration was settled in our quarter ended March 31, 2015 for a total of ¥5.78 billion (or $48.6 million). The Indemnification Holdback is included in acquisition-related liabilities in the long-term liabilities section of the condensed consolidated balance sheet and is expected to be settled in our fiscal year 2016. The RSP Acquisition has been accounted for as a business combination and the results of RSP’s operations have been included in our consolidated financial statements since the Closing Date. Under the terms of the stock purchase agreement, RSP entered into an inventory purchase obligation with Renesas Electronics Corporation, or REL, to acquire Closing Date inventory held by REL. This inventory purchase obligation was settled in the three months ended December 31, 2014 for approximately $115 million.
Our estimate of the fair values of the acquired intangible assets at March 31, 2015 is preliminary and subject to change and is based on established and accepted valuation techniques performed by our third-party valuation specialists. Additional information, which existed as of the Closing Date but is yet unknown to us, may become known to us during the remainder of the measurement period, which will not exceed 12 months from the Closing Date. Changes to amounts recorded as assets or liabilities will be recorded as retrospective adjustments to the provisional amounts recognized as of the Closing Date and may result in a corresponding adjustment to goodwill. During the three months ended March 31, 2015, we made purchase price allocation adjustments, including a $9.7 million decrease to intangible assets, a $2.8 million decrease to deferred tax liability, a $0.5 million increase to current deferred tax asset, and a $0.3 million increase to goodwill. The changes to intangible assets caused us to change our amortization expense retroactively to the previously reported numbers for the three months ended December 31, 2014. Specifically, we reduced the amortization to intangible assets recorded in selling, general, and administrative expenses by $1.5 million and increased the provision for income taxes by $0.5 million.
11
The following table includes the revised provisional amounts recorded for the estimated fair values of the assets acquired and liabilities assumed as of the acquisition date (in thousands):
Cash |
|
$ |
54,705 |
|
Short-term deposit |
|
|
36,614 |
|
Accounts receivable |
|
|
140,210 |
|
Current deferred tax assets |
|
|
3,295 |
|
Inventory |
|
|
6,296 |
|
Property and equipment |
|
|
11,674 |
|
Acquired intangible assets |
|
|
240,900 |
|
Other assets |
|
|
4,002 |
|
Total identifiable assets acquired |
|
|
497,696 |
|
Accounts payable |
|
|
66,544 |
|
Income taxes payable |
|
|
32,534 |
|
Deferred tax liabilities |
|
|
56,751 |
|
Other accrued liabilities |
|
|
28,032 |
|
Net identifiable assets acquired |
|
|
313,835 |
|
Goodwill |
|
|
153,715 |
|
Net assets acquired |
|
$ |
467,550 |
|
Of the $240.9 million of acquired intangible assets, $143.6 million was allocated to developed technology and will be amortized over an estimated weighted average useful life of 5 years; $44.6 million was allocated to customer relationships and will be amortized over estimated useful lives of 2 to 3 years; $22.0 million was allocated to a supplier arrangement and will be amortized over an estimated useful life of less than 1 year; $10.3 million was allocated to backlog and will be amortized over an estimated useful life of less than 1 year; and $20.4 million was allocated to in-process research and development and will be amortized over an estimated useful life that will be determined at the date the underlying projects are deemed to be substantively complete which may occur as early as the fourth quarter of fiscal 2015. Developed technology consists of established small- and medium-sized display driver technology designed for and sold into the smartphone and tablet markets. We preliminarily estimated the fair value of the identified intangible assets using a discounted cash flow model for each of the underlying identified intangible assets. These fair value measurements were based on significant inputs not observable in the market and thus represent a Level 3 measurement. Key assumptions include the level and timing of expected future cash flows, conditions and demands specific to each intangible asset over its remaining useful life, and discount rates we believe to be consistent with the inherent risks associated with each type of asset, which range from 9% to 14%. The fair value of these intangible assets is primarily affected by the projected income and the anticipated timing of the projected income associated with each intangible asset coupled with the discount rates used to derive their estimated present values. We believe the level and timing of expected future cash flows appropriately reflects market participant assumptions.
The value of goodwill reflects the anticipated synergies of the combined operations and workforce of RSP as of the Closing Date.
None of the goodwill is expected to be deductible for income tax purposes. Prior to the RSP Acquisition, we did not have an existing relationship or transactions with RSP. The condensed consolidated financial statements include approximately $475.3 million of revenue from RSP from the Closing Date through March 31, 2015. Earnings contributed by RSP are not separately indentifiable.
The following unaudited pro forma financial information presents the combined results of operations for us and RSP as if the RSP Acquisition had occurred on June 30, 2013. The unaudited pro forma financial information has been prepared for comparative purposes only and does not purport to be indicative of the actual operating results that would have been recorded had the RSP Acquisition actually taken place on June 30, 2013, and should not be taken as indicative of future consolidated operating results. Additionally, the unaudited pro forma financial results do not include any anticipated synergies or other expected benefits from the acquisition.
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
March 31, |
|
|
March 31, |
|
||||||||||
|
|
2015 |
|
|
2014 |
|
|
2015 |
|
|
2014 |
|
||||
|
|
(in thousands, except per share data) |
|
|||||||||||||
Revenue |
|
$ |
477,598 |
|
|
$ |
343,746 |
|
|
$ |
1,435,005 |
|
|
$ |
1,152,450 |
|
Net income/(loss) |
|
|
33,449 |
|
|
|
(32,766 |
) |
|
|
119,310 |
|
|
|
44,932 |
|
Net income/(loss) per share - diluted |
|
|
0.87 |
|
|
|
(0.92 |
) |
|
|
3.08 |
|
|
|
1.23 |
|
12
Pro forma adjustments used to arrive at pro forma net income for the three and nine months ended March 31, 2015 and March 31, 2014, were as follows (in thousands):
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
March 31, |
|
|
March 31, |
|
||||||||||
|
|
2015 |
|
|
2014 |
|
|
2015 |
|
|
2014 |
|
||||
Buyer transaction costs |
|
$ |
— |
|
|
$ |
1,142 |
|
|
$ |
4,300 |
|
|
$ |
1,160 |
|
Amortization of debt issuance costs |
|
|
— |
|
|
|
(250 |
) |
|
|
(250 |
) |
|
|
(750 |
) |
Interest expense |
|
|
— |
|
|
|
(1,222 |
) |
|
|
(1,211 |
) |
|
|
(3,700 |
) |
Intangible amortization |
|
|
3,080 |
|
|
|
(13,116 |
) |
|
|
15,994 |
|
|
|
(65,048 |
) |
Income tax adjustment |
|
|
(1,109 |
) |
|
|
4,722 |
|
|
|
(5,758 |
) |
|
|
23,417 |
|
Total |
|
$ |
1,971 |
|
|
$ |
(8,724 |
) |
|
$ |
13,075 |
|
|
$ |
(44,921 |
) |
8. Acquired Intangibles
The following table summarizes the life, the gross carrying value of our acquired intangible assets, and the related accumulated amortization as of March 31, 2015 and June 30, 2014 (in thousands):
|
|